Physicians' Academy for Cardiovascular Education
SGLT2i in clinical cardiology

SGLT2i in clinical cardiology

EBAC-accredited E-Learning

Online-CME - This course consists of 3 lectures.

During this educational program, the effect of SGLT2 inhibition in patients with cardiorenal syndrome is disscussed in three lectures.

This course consists of the following lectures:

After watching three videos on effects of SGLT2 inhibiton in patients with cardiorenal syndrome, the learner should be able to:

Expert faculty

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating patients with cardiorenal syndrome.

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.


Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim/Lilly.


This is available as accredited online CME for members. Click the button below to enroll:


Share this page with your colleagues and friends: